The acronym SADMANS; sulfonylureas; angiotensin converting enzyme inhibitors (ACEi); diuretics; metformin; angiotensin receptor blockers (ARB); nonsteroidal anti-inflammatory drugs (NSAID); and sodium glucose co-transporter 2 inhibitors (SGLT2i), has been developed as an aid for healthcare professionals to identify medications that could potentially cause harm during an acute illness [9,10] as use of these medications can increase the risk of development of AKI [7]. Here, ACE is linked to acute kidney injury.